Capital for Colleagues Plc Transitions to Access Segment After Aquis Stock Exchange’s Bi-Annual Apex Review

Overview of Aquis Stock Exchange’s Market Structure and Segmentation

Operating from Level 2, 63 Queen Victoria Street in London, Aquis Stock Exchange provides listing and trading services across multiple market segments. Its tiered market structure includes the Apex and Access segments, each with distinct regulatory standards and suitability criteria. The Apex segment caters to growth companies meeting specific capitalisation requirements, while the Access segment serves smaller or emerging businesses. This segmentation enables the exchange to accommodate a broad array of issuers while maintaining appropriate regulatory oversight and investor safeguards within each tier.

The Aquis Growth Market functions under a detailed rulebook, with Chapter 6 outlining the procedures for constituent reviews and segment transfers. These bi-annual reviews ensure companies continue to satisfy eligibility criteria for their segments. The process is systematic and based on objective financial metrics, such as average market capitalisation over defined periods, promoting transparency and consistency in segment classification for investors and market participants.

Details Behind Capital for Colleagues Plc’s Segment Reclassification

Capital for Colleagues Plc, listed under ticker CFCP and ISIN GB00BGCZ2V99, underwent evaluation during the bi-annual constituent review. Its ordinary shares’ average market value over the six months preceding the first Friday of June 2026 fell below the £10 million minimum required to remain in the Apex segment. This threshold is a key eligibility criterion within the Aquis Growth Market Apex Rulebook, and failure to maintain it results in automatic transfer to the Access segment.

This transfer reflects routine regulatory enforcement rather than any misconduct. Market capitalisation fluctuations are common, especially among smaller growth companies. The review’s averaging method over six months smooths short-term volatility, ensuring that only sustained declines below the threshold trigger reclassification. The Access segment offers a fitting environment for companies with reduced market capitalisation, preserving liquidity and regulatory oversight while continuing to provide trading opportunities.

Implementation Date and Regulatory Process for Segment Change

The transfer of Capital for Colleagues Plc to the Access segment became effective on Monday, 20 July 2026, in line with procedures set out in the Aquis Growth Market rulebook. The Regulation Department at Aquis Stock Exchange’s London headquarters issued official notification and oversees the enforcement of these rules. This transparent communication enables investors and market participants to track the reclassification clearly.

The effective date supports an orderly transition, allowing market participants to adjust systems and processes accordingly. Although the segment classification changed, trading and settlement of CFCP shares continue uninterrupted. The swift one-day implementation following the review’s conclusion minimizes investor uncertainty and ensures market classifications accurately reflect current company conditions.

Bi-Annual Review Governance and Regulatory Oversight at Aquis

The bi-annual constituent review is integral to Aquis Stock Exchange’s governance framework. Chapter 6 of the Apex Rulebook defines the timelines, criteria, and procedures for these reviews, which occur twice yearly. This schedule balances the need for regular eligibility assessments with operational stability for listed companies and investors. The objective, rules-based approach removes subjective discretion, relying on financial metrics like average market capitalisation to determine segment eligibility. The independent Regulation Department applies these rules consistently, preserving market integrity and providing clarity to issuers and investors.

Investor Impact and Market Participant Considerations

The reclassification of Capital for Colleagues Plc affects shareholders and market participants by changing the regulatory framework governing CFCP shares. While trading rights remain unchanged, investors should review Access segment regulations to understand differences in disclosure, trading rules, and operational procedures compared to Apex. Dealers, brokers, and intermediaries must update systems to reflect the segment change, though trading and settlement processes largely remain the same. Public information did not indicate an immediate share price impact, as junior market prices are influenced by multiple factors including fundamentals and market sentiment. Investors should monitor official data and company updates for developments related to liquidity or trading conditions.

Comparison Between Apex and Access Segment Criteria

The Apex segment targets growth companies with higher market capitalisation and investor sophistication, requiring a minimum average market value of £10 million. Companies below this threshold, like Capital for Colleagues Plc, are moved to the Access segment, which supports smaller or earlier-stage businesses. This tiered structure allows the exchange to tailor regulatory requirements to company size and maturity, facilitating capital formation across different development stages.

The Access segment remains a regulated and legitimate platform for public trading and capital raising, often serving as a starting point for growth companies that may later progress to Apex status. Segment transfers are a normal part of market dynamics reflecting valuation changes rather than negative developments. The rulebook provides clear mechanisms for movement between segments based on average market capitalisation.

Contact Information and Additional Resources from Aquis Regulation

For further details on the segment transfer or regulatory requirements, investors and market participants can contact Aquis Stock Exchange’s Regulation Department at 0203 597 6361 or via email at [email protected]. The exchange’s website, www.aquis.eu, offers access to the full rulebook, including Chapter 6 governing constituent reviews and segment changes. The Regulation Department provides clarifications, explains regulatory decisions, and assists issuers and market participants with compliance inquiries.

Aquis maintains comprehensive records of announcements and regulatory notices, ensuring transparency and enabling stakeholders to stay informed about segment compositions. Those affected by the segment change—whether investors, brokers, or other stakeholders—are encouraged to consult published rules or contact the Regulation Department for guidance. This commitment to clear communication reflects Aquis’s role as a London-based market infrastructure provider serving the UK investment community.

Context of Growth Market Standards and Aquis’s Market Evolution

The Aquis Growth Market operates within the UK regulatory environment, offering listing options for companies that may not meet the London Stock Exchange’s main market requirements. Its tiered segments support capital access for smaller, emerging, and established companies while maintaining appropriate regulatory standards. The bi-annual constituent reviews and segment transfers ensure the market structure remains aligned with company characteristics and market conditions.

The recent transfer of Capital for Colleagues Plc exemplifies Aquis’s systematic, rules-based approach to market management, providing stability and predictability for companies and investors. The bi-annual schedule balances thorough oversight with operational continuity, preventing the accumulation of ineligible companies while minimizing unnecessary changes. As UK financial markets evolve, Aquis’s segmented growth market continues to facilitate capital formation and public market access tailored to company development stages.